Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now. |
Exploratory/Developmental Program for Translational Research in Muscular Dystrophy (R21)
Release Date: November 30, 2005
Announcement Number: PAR-06-043
Application Receipt Date:
February 1, 2006
May 1, 2006
Funding Contact: John Porter, Ph.D.
Program Area: Channels, Synapses and Neural Circuits
Brief Description:
The National Institute of Neurological Disorders and Stroke and the National Institute of Arthritis and Musculoskeletal and
Skin Diseases solicit applications for translational research projects in muscular dystrophy. Several emerging pathways to
treatment of muscular dystrophy show promise, ranging from palliative therapies that can markedly delay onset or progression
of the disease to genetic or stem cell approaches that may reverse or eliminate the condition. The objective of this initiative
is to encourage the pursuit of a broad range of translational research strategies for therapeutic development in muscular
dystrophy. This Program Announcement (PA) solicits exploratory/developmental applications that will provide the leads, tools,
and resources needed for a subsequent therapy development project. Applications are encouraged for translational research
exploratory/developmental projects for any one or more of the muscular dystrophies.
Choose an option to view additional funding announcements |
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives |